EU Clinical Trial 2018-002210-12

A multi-center, open-label, uncontrolled, single-arm, extension study to determine the long-term safety and tolerability of oral lucerastat in adult subjects with Fabry disease  Mar 18, 2019

Main objective of the trial: To determine the long-term safety and tolerability of lucerastat in subjects with Fabry disease

Parties

Sponsors